Seattle biotech Atossa Therapeutics eyes acquisition of unnamed company
July 11, 2022 at 17:25 PM EDT
Atossa has paid $3 million for exclusive rights to negotiate the deal. The target company focuses on a form of cancer treatment.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
